
29.04.2025 • News
Merck & Co. Breaks Ground on $1 Billion Biologics Center in US
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.